Results for tag: "Cough Hypersensitivity Syndrome Drug"

The Cough Hypersensitivity Syndrome Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat chronic cough, a condition characterized by an excessive and persistent cough. These drugs are typically used to reduce the frequency and intensity of coughing, as well as to reduce the associated symptoms of chest pain, throat irritation, and difficulty breathing. Commonly used drugs in this market include anticholinergics, beta-agonists, and leukotriene receptor antagonists. The Cough Hypersensitivity Syndrome Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in this market include GlaxoSmithKline, Merck & Co., AstraZeneca, Pfizer, Novartis, and Boehringer Ingelheim. Show Less Read more